[1]
S. Lee, M. Chary, I. Salehi, and R. Bansal, “IMMUNE-MEDIATED ADALIMUMAB-INDUCED THROMBOCYTOPENIA FOR THE TREATMENT OF ULCERATIVE COLITIS”, Int J Pharm Pharm Sci, vol. 7, no. 7, pp. 456–458, Jul. 2015.